Christopher Haqq

Chief Medical Officer, Atara Biotherapeutics, Inc.

Companies

Elicio Therapeutics, Inc.Officer Jun 12, 2023 to now¹
Surrozen, Inc./DEBoard member Nov 18, 2020 to Nov 18, 2020²
Atara Biotherapeutics, Inc.Chief Medical Officer Oct 15, 2014 to Feb 19, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Elicio Therapeutics, Inc. ELTX57,381 shares⁴$87.2K at $1.52Feb 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 2, 2026Granted 25,400 shares of Elicio Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARElicio Therapeutics, Inc., Officer
2
SEC EDGARSurrozen, Inc./DE, Board member
3
SEC EDGARAtara Biotherapeutics, Inc., Chief Medical Officer
4
SEC EDGARElicio Therapeutics, Inc. shares after the filing of Feb 2, 2026